Document is current

Article History

Received: 16 September 2024

Accepted: 25 February 2025

First Online: 1 March 2025

Declarations

:

: The four pilot countries (Greece, the Netherlands, Spain, and the UK) obtained approval for the study from their corresponding Ethics Committee. Greece: The study was approved by the Bioethics Committee of Harokopio University (ethical approval code: 953/10-3-2021). The Netherlands: The Medical Research Ethics Committee of the Erasmus Medical Centre, Rotterdam, The Netherlands granted permission to execute this study and for publications in a later stage of the study (permission ID: MEC-2021-0396). Spain: The Drug Research Ethics Committee (CEIm) of the Pere Virgili Health Research Institute (Reus, Spain) granted permission to execute this study and for publications in a later stage of the study (n° Ref. CEIM: 085/2021). The UK: The study has been approved by the Sport and Health Sciences Ethics Committee of the University of Exeter, ref. numbers (21-03-24-B-02, 21-07-14-B-04).The SEEDS intervention has adhered to the principles of the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice guideline.

: Not applicable.

: The authors declare no competing interests.